Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth



Status:Recruiting
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - Any
Updated:9/16/2018
Start Date:September 2016
Contact:Rupsa C Boelig, MD
Email:rupsa.boelig@jefferson.edu

Use our guide to learn which trials are right for you!

The purpose of this study is to evaluate the two suggested therapies for prevention of
recurrent preterm birth (PTB) in women with a prior spontaneous preterm birth, vaginal and
intramuscular progesterone to determine whether vaginal progesterone is superior to
intramuscular progesterone in the prevention of recurrent preterm birth.

Preterm birth is one of the leading causes of neonatal morbidity and mortality. One of the
greatest predictors of preterm birth is a history of prior spontaneous preterm birth.
Presently 17 hydroxyprogesterone caproate (intramuscular) is the only FDA approved product
for the prevention of recurrent preterm birth, however recent studies suggest that vaginal
progesterone may be used for this purpose, and may even be superior. The American College of
Obstetrics and Gynecology does not specify the optimal route of progesterone administration
for the prevention of recurrent preterm birth. It is our intention to compare vaginal and
intramuscular progesterone to see if one is superior.

Inclusion Criteria:

- Pregnant women with singleton pregnancies

- ≥18 years old

- Estimated gestational age less than 24 0/7 weeks

- Prior spontaneous preterm birth of a singleton pregnancy between 16 0/7-36 6/7 weeks.

- Patients are also required provide consent, demonstrate an understanding of the
purpose of the study, and agree to the study protocol.

Exclusion Criteria:

- History of an adverse reaction to progesterone;

- A contraindication to progesterone treatment;

- Placenta previa or accreta;

- Major fetal anomaly diagnosed on ultrasound or known chromosomal disorder;

- Multifetal gestation;

- Preterm labor, premature rupture of membranes, or clinical chorioamnionitis, at the
time of enrollment
We found this trial at
3
sites
Washington, District of Columbia 20052
?
mi
from
Washington,
Click here to add this to my saved trials
111 S 11th St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Thomas Jefferson University Hospital Our hospitals in Center City Philadelphia share a 13-acre campus with...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
759 Chestnut Street
Springfield, Massachusetts 01199
(413) 794 - 0000
Baystate Medical Center Baystate Medical Center (BMC), in Springfield, Massachusetts, is an academic, research, and...
?
mi
from
Springfield, MA
Click here to add this to my saved trials